Company Directory > CRO > AWINSA Life Sciences
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of AWINSA Life Sciences and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
AWINSA Life Sciences is a specialized Contract Research Organization (CRO) focused on providing end-to-end pharmacovigilance, clinical safety, medical information, and regulatory services. The company supports pharmaceutical and biotechnology firms globally by managing adverse event reporting, signal detection, medical monitoring, and ensuring regulatory compliance across the drug lifecycle. With operations spanning the United States, Europe, and Asia, AWINSA serves as a strategic partner for companies navigating complex safety requirements. Their services include case processing, risk management planning, audit readiness, and medical writing, aimed at maintaining high-quality safety standards for clinical trials and post-marketing surveillance.
CLASSIFICATION
Company Type:CRO
Industry:CRO
Sub-Industry:Pharmacovigilance and Clinical Safety
SIZE & FINANCIALS
Employees:51-200
Revenue:$1M-$5M
Founded:2018
Ownership:private
Status:operating
FUNDING
Total Raised:$0
0
CORPORATE STRUCTURE
Key Partnerships:Asklepion Pharmaceuticals (Clinical safety and pharmacovigilance service provider)
COMPETITION
Position:Niche Player
Competitors:InSilicoTrials, Revolution Medicine, Pharmetheus
LEADERSHIP
Key Executives:
Sanjeev Miglani - Founder and Director
Mugdha Chopra - Co-Founder and Director
Dr. Arun Ram - Medical Director of Pharmacovigilance and Medical Affairs
Scientific Founders:Sanjeev Miglani
LINKS
Website:awinsals.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with AWINSA Life Sciences. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.